DR LALCHANDANI LABS Fact Sheet, DR LALCHANDANI LABS Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR LALCHANDANI LABS Fact Sheet    (DLLL)


Alert: Discover the Makings of Potential 'Crorepati' Stocks from Richa Agarwal


Here is the latest financial fact sheet of DR LALCHANDANI LABS. For more details, see the DR LALCHANDANI LABS quarterly results and DR LALCHANDANI LABS share price and chart. For a sector overview, read our pharmaceuticals sector report.

DR LALCHANDANI LABS Price History

Price Rs 41.5
Mkt Cap Rs m 180
Vol '000 16.0
P/E X  
P/CF X 11.8
EPS (TTM) Rs 0.0
1 Day % 8.9
No. of shares m 4.33
1 Week % 7.2
1 Month % -3.5
1 Year % 172.1
52 week H/L Rs 52.5/10.8
As on Jan 14, 2022 (Close)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

DR LALCHANDANI LABS Financials

No. of Mths
Year Ending
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
DR LALCHANDANI LABS EQUITY SHARE DATA
High RsNA322218 
Low RsNA1887 
Sales per share (Unadj.) Rs9.512.214.122.6 
Earnings per share (Unadj.) Rs0.91.21.12.3 
Diluted earnings per shareRs0.61.21.12.3 
Cash flow per share (Unadj.) Rs1.32.02.13.5 
Dividends per share (Unadj.) Rs0000 
Adj. dividends per shareRs0.000.000.000.00 
Avg Dividend yield %NM000 
Book value per share (Unadj.) Rs11.418.619.722.1 
Adj. book value per shareRs7.718.619.722.0 
Shares outstanding (eoy) m2.934.334.334.33 
Bonus / Rights / Conversions  ---- 
Price / Sales ratio x02.01.10.5 
Avg P/E ratio x019.913.65.2 
P/CF ratio (eoy) x012.07.23.4 
Price / Book Value ratio x01.30.80.6 
Dividend payout %0000 
Avg Mkt Cap Rs m01066553 
No. of employees `000NANANANA 
Total wages/salary Rs m3764 
Avg. sales/employee Rs ThNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNM 
DR LALCHANDANI LABS INCOME DATA
Net Sales Rs m28536198 
Other income Rs m0000 
Total revenues Rs m28536198 
Gross profit Rs m6121322 
Depreciation Rs m1345 
Interest Rs m2124 
Profit before tax Rs m47714 
Minority Interest Rs m0000 
Prior Period Items Rs m0000 
Extraordinary Inc (Exp) Rs m0000 
Tax Rs m1224 
Profit after tax Rs m35510 
Gross profit margin %22.122.820.823.0 
Effective tax rate %26.025.828.226.6 
Net profit margin %9.410.17.810.3 
DR LALCHANDANI LABS BALANCE SHEET DATA
Current assets Rs m37587686 
Current liabilities Rs m16141929 
Net working cap to sales %77.384.193.558.2 
Current ratio x2.44.14.13.0 
Inventory Days Days46393343 
Debtors Days Days149127198,974,733148,580,231 
Net fixed assets Rs m24384064 
Share capital Rs m29434343 
"Free" reserves Rs m4374252 
Net worth Rs m33818596 
Long term debt Rs m1361526 
Total assets Rs m62101119152 
Interest coverage x3.26.34.64.9 
Debt to equity ratio x0.40.10.20.3 
Sales to assets ratio x0.40.50.50.6 
Return on assets %6.86.65.59.0 
Return on equity %7.96.65.610.6 
Return on capital %11.19.98.514.2 
Exports to sales %0000 
Imports to sales %0000 
Exports (fob) Rs m0000 
Imports (cif) Rs m0000 
Fx inflow Rs m0000 
Fx outflow Rs m0000 
Net fx Rs m0000 
DR LALCHANDANI LABS CASH FLOW
From Operations Rs m 6 -4 -1 12 
From Investments Rs m -13 -19 -5 -23 
From Financial Activity Rs m 16 35 9 17 
Net Cashflow Rs m 9 11 2 6 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 60.8%
Institution 0.0%
Non-Institution 39.2%
Total 100.0%
Free Float 39.2%
Pledged promoter holdings 0.0%
Shareholding as on Sep 2021
 

Company Information

Regd Off M-20 Basement, Greater Kailash, Part-1 South Delhi, New Delhi - 110048
E-mail info@lalchandanipathlab.com Web www.lalchandanipathlab.com
Tel 011 49057058/59 Fax
Sector HOSPITAL & HEALTHCARE SERVICES Group Private sector
Tr Agent Cameo Corporate Services Ltd, Subramanian Buildings No 1, Club House Road
YEAR OF INC: 2011 BSE CODE: 541299 FV (Rs): 10 DIV YIELD (%): -

More Hospital & Healthcare Services Company Fact Sheets:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    

Compare DR LALCHANDANI LABS With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    




Today's Market

Indian Indices End Flat Amid Volatility; Asian Paints, Axis Bank & HUL Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Views on news

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

India's Best Semiconductor Stocks Views On News (Views On News)

Jan 7, 2022

Modern wars are fought with semiconductors. India's best semiconductor stocks have big tailwinds from defence and manufacturing.

10 Indian Companies with the Fastest Growth in Dividend Payouts... (Views On News)

Jan 10, 2022

These companies have been consistently paying higher dividends for several years.

Tata Steel vs SAIL: Which Stock is Better? (Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Looking for Consistent Compounding Stocks? Here's a Watchlist for You (Views On News)

Jan 6, 2022

These companies have generated mind boggling returns for investors over the years.

My Best Sectors for 2022 (Fast Profits Daily)

Jan 4, 2022

My top 2 sectors for 2022 might surprise you.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK DR LALCHANDANI LABS

  • Track your investment in DR LALCHANDANI LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR LALCHANDANI LABS

DR LALCHANDANI LABS - KMC SPECIALITY HOSPITALS COMPARISON

COMPARE DR LALCHANDANI LABS WITH

MARKET STATS